P12. Combination of radiotherapy and chemotherapy with dendritic cell immunotherapy in glioblastoma patients induces NK and NKT cell responses by S Pellegatta et al.
POSTER PRESENTATION Open Access
P12. Combination of radiotherapy and
chemotherapy with dendritic cell
immunotherapy in glioblastoma patients
induces NK and NKT cell responses
S Pellegatta1*, M Eoli1, MG Bruzzone2, S Cuzzubbo1, E Anghileri1, C Antozzi3, S Frigerio4, B Pollo5, EA Parati4,
G Finocchiaro1
From 1st Immunotherapy of Cancer Conference (ITOC1)
Munich, Germany. 12-14 March 2014
Background
Two clinical studies including the treatment of first
diagnosis and recurrent glioblastoma (GB) patients with
dendritic cells (DCs) loaded with autologous tumour
lysate (Nava et al, 2012) are currently active at Istituto
Neurologico Besta, Milan.
Our first results obtained on a group of recurrent GB
patients demonstrated that the response of NK cells cor-
relates with a significantly prolonged survival (Pellegatta
et al, 2013).
Material and methods
We have examined 17 patients with primary GB receiving
standard radio and chemotherapy with temozolomide
(RT-TMZ) after leukapheresis and TMZ in combination
with DC vaccines. The median age at surgery was 57 y
(range: 23–70). Peripheral Blood Lymphocytes (PBLs)
were analysed by flow cytometry to identify CD8+
T cells, NK and NKT cells before and after DC vaccines.
The ratio of vaccination/baseline frequencies (V/B ratio)
of all of the immunological parameters for each patient
was calculated, and the median of all of the observations
used as the cut off value to separate patients into the
‘low’ or ‘high’ groups.
Results
RT-TMZ induced significant lymphopenia (<1000 lym-
phocytes/microl)) in 13/17 patients (76.4%). V/B ratio
was correlated with the progression free survival (PFS)
of each patient. Increased V/B ratio for NK cells and in
particular NKT cells, but not for CD8 T lymphocytes,
was significantly associated with prolonged PFS (median
PFS 15 vs 8.5 mo, p=0.03; 15.0 vs 8.0 mo, p=0.002, respec-
tively). Responder patients (PFS ≥ 12) showed increased
expression of interferon (IFN)-g immediately after the sec-
ond vaccination as evaluated by real time-PCR.
No changes in the expression levels of IFN-g were
observed in the other patients.
Conclusions
Our results encourage further investigation on the role of
NK and NKT cells in anti-tumour responses and on possi-
ble interference of radio-chemotherapy on activation of
CD8+ T cells.
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